The Value of Confidential Policy Information: Persuasion, Transparency, and Influence
The Journal of Law, Economics, and Organization · 20.05.2022 · 38 (2) · 570-612
DOI: 10.1093/jleo/ewab020 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Law, Economics, and Organization, online erschienen am 14.12.2021. Verfasst von Clement Minaudier. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Economic and Social Research Council.
Abstract (Originalsprache)
Transparency of the lobbying process is hailed as an effective means to limit the influence of special interest groups, but should transparency also apply to the information obtained by policy makers (PMs)? This article extends theories of informational lobbying by explicitly modeling the choice of PMs to obtain information before interacting with lobbyists. This approach reveals a new channel for the value of confidentiality: extracting evidence from special interest groups. It shows that, counter-intuitively, the influence of special interest groups can increase as PMs become more expert. These results shed light on the relationship between confidentiality, good governance, and influence.
Förderung
- Economic and Social Research Council
Zitieren
APA
Minaudier, C. (2022). The Value of Confidential Policy Information: Persuasion, Transparency, and Influence. The Journal of Law, Economics, and Organization, 38(2), 570-612. https://doi.org/10.1093/jleo/ewab020
Vancouver
Minaudier C. The Value of Confidential Policy Information: Persuasion, Transparency, and Influence. The Journal of Law, Economics, and Organization. 2022;38(2):570-612. doi:10.1093/jleo/ewab020
BibTeX
@article{Minaudier2022,
author = {Minaudier, Clement},
title = {The Value of Confidential Policy Information: Persuasion, Transparency, and Influence},
journal = {The Journal of Law, Economics, and Organization},
year = {2022},
volume = {38},
number = {2},
pages = {570--612},
doi = {10.1093/jleo/ewab020}
}
EUVIMED